未知股票 FNCH 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 160.58万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 2.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Finch Therapeutics Group：收到纳斯达克的来信通知公司上市小组已决定将公司从纳斯达克退市
Finch Therapeutics Group：收到纳斯达克的来信通知公司上市小组已决定将公司从纳斯达克退市
2024-05-24 18:10
Seth Klarman's Baupost cuts Warner Bros. stake, takes in SoundHound, among others
Billionaire investor Seth Klarman's Baupost Group cut its stake in Warner Bros. Discovery (NASDAQ:WBD), exited its position in Tower Semiconductor (NASDAQ:TSEM) and snapped up some shares in SoundHoun...
2024-05-15 06:51
Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer
Dr. Kassam will lead Seed Health's clinical research and medical affairs, driving the development and validation of the company's microbiome health innovations and enhancing practitioner eng...
2024-04-24 20:15
Finch Therapeutics Gr Q3 EPS $(1.51) Up From $(25.38) YoY
Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.51) per share. This is a 94.05 percent increase over losses of $(25.38) per share from the same period last year.
2023-11-08 19:35
Finch Announces Reverse Stock Split of Common Stock
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. ("Finc...
2023-06-09 19:00
HC Wainwright & Co. Reiterates Buy on Finch Therapeutics Gr, Maintains $7 Price Target
HC Wainwright & Co. analyst Vernon Bernardino reiterates Finch Therapeutics Gr (NASDAQ:FNCH) with a Buy and maintains $7 price target.
2023-05-12 21:31
Finch Therapeutics Group, Inc. 预计将公布 FY2023 每股收益0.57美元（纳斯达克股票代码：FNCH）
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Rating) – Stock analysts at H...
2023-04-06 21:52
Finch Therapeutics Group, Inc. 预计2023年第一季度每股收益为0.09美元（纳斯达克股票代码：FNCH）
Finch Therapeutics Group, Inc. (NASDAQ:FNCH – Get Rating) – Equities researcher...
2023-04-06 13:32
正面对比：Aptose Biosciences（纳斯达克股票代码：APTO）与芬奇疗法集团（纳斯达克股票代码：FNCH）
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Finch Therapeutics Group (NAS...
2023-04-02 13:42
Finch Therapeutics Group(FNCH.US)：2022年Q4财报实现营收8000美元，前值为80.6万美元，预期值为40万美元
Finch Therapeutics Group(FNCH.US)：2022年Q4财报实现营收8000美元，前值为80.6万美元，预期值为40万美元，比市场预期...
2023-03-24 05:50
